Serum neopterin levels in patients with replicative and nonreplicative HBV carriers
2006

Neopterin Levels in Hepatitis B Carriers

Sample size: 85 publication Evidence: moderate

Author Information

Author(s): Kaleli Ilknur, Demir Melek, Cevahir Nural, Yılmaz Mustafa, Demir Suleyman

Primary Institution: Pamukkale University Medical Faculty

Hypothesis

The study aims to define the pattern of neopterin levels in replicative and nonreplicative HBV carriers.

Conclusion

Elevated neopterin levels may indicate the presence of viral replication in hepatitis B infected carriers.

Supporting Evidence

  • Serum neopterin concentrations were significantly higher in replicative HBV carriers compared to controls.
  • In the nonreplicative group, neopterin levels were not significantly different from controls.
  • The study included a total of 85 participants, including healthy controls.

Takeaway

This study looked at how a substance called neopterin behaves in people with hepatitis B. It found that those with active virus replication had higher levels of neopterin.

Methodology

The study included 30 replicative HBV carriers, 25 nonreplicative HBV carriers, and 30 healthy controls, measuring serum neopterin levels using enzyme-linked immunosorbent assay.

Limitations

The study did not explore the correlation between neopterin levels and HBV DNA levels in detail.

Participant Demographics

Participants included 55 HBV infected patients aged 13 to 73 years, with a mix of 13 females and 17 males in the replicative group, and 10 females and 15 males in the nonreplicative group.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2334-6-157

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication